US 10053468
Heterocyclic compound
granted A61PA61P1/04A61P11/06
Quick answer
US patent 10053468 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Aug 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P1/04, A61P11/06, A61P17/00, A61P17/06